Cargando…
Valproate induced hyperammonemic encephalopathy treated by haemodialysis
Valproate (VPA)-induced hyperammonemic encephalopathy is an unusual, but serious, adverse effect of divalproex sodium (DVPX) treatment and if untreated can lead to raised intracranial pressure, seizures, coma, and eventually death. It can, however, be reversed if an early diagnosis is made. It is th...
Autores principales: | Chauhan, Vinay Singh, Dixit, Siddarth, Goyal, Sunil, Azad, Sudip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810177/ https://www.ncbi.nlm.nih.gov/pubmed/29456331 http://dx.doi.org/10.4103/ipj.ipj_37_16 |
Ejemplares similares
-
Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014) -
A Case of Valproate Induced Hyperammonemic Encephalopathy
por: Tarafdar, Surjit, et al.
Publicado: (2011) -
Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017) -
Valproate-induced hyperammonemic encephalopathy: a case report
por: Shah, Suhal, et al.
Publicado: (2020) -
Severe valproate induced hyperammonemic encephalopathy successfully managed with peritoneal dialysis
por: Kumar, Amandeep, et al.
Publicado: (2014)